DigiFab (Digibind) Dosing for Digoxin Poisoning

ورودی‌های بالینی بیمار

حداقل ۰.۵ — حداکثر ۶۲۰ • واحد: kg

حداقل ۰ — حداکثر ۱۰۰ • واحد: ng/mL

حداقل ۰ — حداکثر ۱۰۰ • واحد: mg

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
digifab vials
—vials
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Low dose1–2
  • Moderate dose3–6
  • High dose7–10
  • Very high dose11–20
Direct Clinical Answer

The DigiFab (Digibind) Dosing for Digoxin Poisoning calculates assessing acute poisoning severity, antidote indications, and fatal toxicity trajectory. Key inputs include method. Scores guide administering specific antidote therapy, gastrointestinal decontamination, and continuous telemetry monitoring. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Doses DigiFab in patients with confirmed digoxin poisoning or overdose

Clinical Indication

The DigiFab (Digibind) Dosing for Digoxin Poisoning is indicated for bedside clinical practice to support Doses DigiFab in patients with confirmed digoxin poisoning or overdose. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with acute pharmaceutical overdose, agricultural pesticide ingestion, toxic gas inhalation, or venomous envenomation. Clinical application is indicated across Poison control centers, acute toxicology wards, emergency resuscitation rooms, and intensive care.

Limitations & Contraindications

Initial serum concentrations for sustained-release or co-ingested anticholinergic agents may falsely appear low before delayed absorption peaks.

Clinical Pearls & Action Plan

Rapid clinical toxidrome identification guides immediate antidote administration; do not wait for confirmatory toxicology assays.

Formula & Variables:

For serum level method: Number of vials = (serum digoxin level [ng/mL] × patient weight [kg]) / 100. For amount ingested method: Number of vials = (amount ingested [mg] / 0.5 mg/vial) × 0.8 (80% bioavailability). Always round up to the next whole number.

Input Parameters

NameTypeRequiredDescription
methodstringYesCalculation method to use
weight_kgfloatNoPatient body weight in kilograms (required for serum level method)(kg)
serum_digoxin_levelfloatNoSerum digoxin level in ng/mL (required for serum level method)(ng/mL)
amount_ingested_mgfloatNoTotal amount of digoxin ingested in mg (required for amount ingested method)(mg)

Score Interpretation & Guidance

RangeStageDescription
1–2Low doseLow dose requirement
3–6Moderate doseModerate dose requirement
7–10High doseHigh dose requirement
11–20Very high doseVery high dose requirement
21–999Extreme doseExtreme dose requirement

Evidence-Based References (EBM)

  • Lapostolle F, Borron SW, Verdier C, et al. Digoxin-specific Fab fragments as single first-line therapy in digitalis poisoning. Crit Care Med. 2008;36(11):3014-8.
  • Antman EM, Wenger TL, Butler VP Jr, Haber E, Smith TW. Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments. Final report of a multicenter study. Circulation. 1990;81(6):1744-52.
  • Bismuth C, Gaultier M, Conso F, Efthymiou ML. Hyperkalemia in acute digitalis poisoning: prognostic significance and therapeutic implications. Clin Toxicol. 1973;6(2):153-62.

Related calculators